LANSING, Mich., Jan. 24, 2017 /PRNewswire/ -- Neogen
Corporation (NASDAQ: NEOG) announced today that it had terminated
its agreement with SenesTech Incorporated (NASDAQ: SNES) related to
the manufacturing and marketing of a rodenticide being developed by
SenesTech. The two firms had worked together since 2014 — prior to
the time when the SenesTech product was approved by the U.S.
Environmental Protection Agency.
"The final EPA approval provided that the product could only be
used by a Licensed Pesticide Applicator. Further, the product
is approved as a contraceptive for rodents and must be continually
fed," said James Herbert, Neogen CEO
and chairman. "Whereas the product may have use in some
applications, it would face very limited use in the food and
agricultural industry where Neogen is focused. We wish the
SenesTech team success as they go forward with their plans to
commercialize this contraceptive product."
Neogen Corporation develops and markets products dedicated to
food and animal safety. The company's Food Safety Division markets
dehydrated culture media, and diagnostic test kits to detect
foodborne bacteria, natural toxins, food allergens, drug residues,
plant diseases and sanitation concerns. Neogen's Animal Safety
Division is a leader in the development of animal genomics along
with the manufacturing and distribution of a variety of animal
healthcare products, including diagnostics, pharmaceuticals,
veterinary instruments, wound care and disinfectants.
CONTACT:
Steven J.
Quinlan
Neogen Vice President &
CFO
517/372-9200
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/neogen-announces-senestech-agreement-cancellation-300395522.html
SOURCE Neogen Corporation